TP53 and neoplasm: Studies have shown that mutant p53 leads to the release of miR-1246-rich exomes, causing M1 macrophages to polarize into tumor-promoting M2 phenotype, thereby contributing to the establishment of an immunosuppressive and inflammatory TME (82–85).